Industry News

Medanta- The Medicity, introduced Vacuum Assisted Breast Biopsy Technology for the treatment of breast cancer.

Breast canceris cancer that develops from breast tissue.In India, number of young and middle aged women suffering from disease.

Ideal Cures Pvt Ltd, has received third EXCiPACT certificate for its manufacturing site located at Vasai. The plant at Vasai, the main manufacturing unit of the company, has received EXCiPACT certification for film coating materials (Instacoat, Instanute, Instaspray, and Instamask) and extended cooling boosters (Ecocool). With receipt of this third certificate all manufacturing plants of Ideal Cures located in India at Vasai, Jammu and Khambhat are EXCiPACT certified.

Teijin Pharma Limited, the core company of the Teijin Group’s medical and pharmaceutical business,  has launched Mucosolvan L tablet 45 mg (ambroxol hydrochloride), a reduced-size tablet version of the company's novel expectorant drug.

SkylineDx, a Dutch-based innovative biotechnology company specialising in the development and commercialization of genetic tests, has launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods.

[adsense:336x280:8701650588]

Lupin, India's fifth largest drug maker, announced the acquisition of Russia's Biocom, a fast-growing generic pharmaceuticals firm, for an undisclosed amount.
Lupin Chief Executive Officer, Vinita Gupta, said: "We are excited about our entry into the Russian market through Biocom. Russia is an attractive market and this acquisition will also enable our expansion into neighbouring markets as well as other Eastern European markets in the future."

Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, launch generic Aggrenox (aspirin/extended-release dipyridamole) capsules in the United States which are used to lower the risk of stroke in people who have had a mini-stroke (transient ischemic attack or TIA) or stroke due to a blood clot.

Glenmark Pharmaceuticals, has received approval from the US Food and Drug Administration (US FDA) for its cholesterol-lowering drug Ezetimibe. Ezetimibe is the generic version of Merck-Schering Plough's cholesterol-lowering drug with the product name Zetia.

Multiplicom N.V., announced the launch of a new gene panel, the CLL MASTR Plus kit, to improve the diagnosis of patients with chronic lymphocytic leukaemia.

US Food and Drug Administration (FDA) has granted marketing authorisation for morphine sulfate ER tablets. A subsidiary of Zydus Pharmaceuticals (USA) Inc., Nesher has considerable expertise in niche therapies with development or products barriers, such as controlled release medications and DEA-controlled substances. Morphine sulfate ER tablets used in the treatment of chronic pain or cancer related pain. The product will be manufactured at Nesher Pharmaceuticals (USA) LLC, located at St. Louis, USA.